Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amirix Imaging was a biotechnology company focused on the development of advanced molecular imaging technologies and radiopharmaceuticals. The company specialized in creating high-resolution imaging systems designed to improve the detection and monitoring of various diseases, including cancer and neurological disorders. Their technology aimed to provide clinicians with more precise diagnostic tools by integrating novel imaging agents with sophisticated hardware. Amirix Imaging was eventually acquired, and its core technologies were integrated into the broader portfolio of its parent organization to enhance medical imaging capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amirix Imaging.